{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:13:03Z","timestamp":1775808783123,"version":"3.50.1"},"reference-count":32,"publisher":"The Ewha Medical Journal, Ewha Womans University College of Medicine","issue":"4","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100008544","name":"Korean Dermatological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008544","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.e-emj.org"],"crossmark-restriction":true},"short-container-title":["Ewha Med J"],"abstract":"<jats:p>\n                Treatment should be initiated for all suspected, clinical, or confirmed cases of\n                    scabies. Patients affected should be adequately isolated, and high-risk groups\n                    with close contact histories should be treated regardless of their symptoms.\n                    Optimal treatment strategies can be selected based on age, clinical subtype, and\n                    the patient's health status. In Korea, commercially available\n                    preparations for scabies treatment include topical 5% permethrin, topical 10%\n                    crotamiton, and oral ivermectin. Topical 5% permethrin is the first-line\n                    selective treatment for both classic and crusted scabies. Alternative treatments\n                    include topical 10% crotamiton and oral ivermectin. After completing treatment,\n                    follow-up visits at 2 and 4 weeks are recommended to monitor the therapeutic\n                    response. Treatment is considered to have failed if scabies mites or burrows are\n                    detected, new clinical characteristics develop, or there is an aggravation of\n                    pruritus. Scabies itch should be adequately managed with emollients, oral\n                    antihistamines, and topical corticosteroids. Preventive measures, including\n                    personal hygiene, patient education, and environmental control, should besd\n                    implemented to reduce the transmission of scabies.\n            <\/jats:p>","DOI":"10.12771\/emj.2024.e72","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:17:09Z","timestamp":1731457029000},"update-policy":"https:\/\/doi.org\/10.12771\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical practice guidelines for the diagnosis and treatment of\n                    scabies in Korea: Part 2. Treatment and prevention \u2014 a secondary\n                    publication"],"prefix":"10.12771","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8830-5479","authenticated-orcid":false,"given":"Jin","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7295-5725","authenticated-orcid":false,"given":"Soon-Hyo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-2479","authenticated-orcid":false,"given":"Young Bok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0576-0474","authenticated-orcid":false,"given":"Hei Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-7573","authenticated-orcid":false,"given":"Jie Hyun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5766-0179","authenticated-orcid":false,"given":"Gwang Seong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4998","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"issue":"6","key":"key2.0241212065459e+13_B1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/jamadermatol.2019.0279","article-title":"Evaluation of ivermectin vs permethrin for treating scabies:\n                        summary of a Cochrane review","volume":"155","author":"Rosumeck","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"6","key":"key2.0241212065459e+13_B2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/ced.14209","article-title":"In vitro survival of scabies mites","volume":"45","author":"Pallesen","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"key2.0241212065459e+13_B3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00105-020-04561-y","article-title":"Skabiestherapie in Deutschland: ergebnisse einer bundesweiten\n                        umfrage mit besonderem fokus auf die wirksamkeit der erstlinientherapie mit\n                        permethrin","volume":"71","author":"Hackenberg","year":"2020","journal-title":"Hautarzt"},{"issue":"9","key":"key2.0241212065459e+13_B4","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1111\/jdv.17339","article-title":"Is scabies becoming less sensitive to permethrin\n                        therapy?","volume":"35","author":"Mazzatenta","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"key2.0241212065459e+13_B5","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1080\/09546634.2020.1774489","article-title":"\u2018Loss of efficacy of topical 5% permethrin for treating\n                        scabies: an Austrian single-center study\u2019","volume":"33","author":"Meyersburg","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"key2.0241212065459e+13_B6","volume-title":"Resources of health professionals - medication, in: parasites \u2013\n                        scabies [Internet]","author":"Centers for Disease Control and Prevention (CDC)\u2019s Division\n                            of Parasitic Diseases and Malaria","year":"2023"},{"issue":"8","key":"key2.0241212065459e+13_B7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jdv.14351","article-title":"European guideline for the management of scabies","volume":"31","author":"Salavastru","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"key2.0241212065459e+13_B8","first-page":"991","article-title":"Guideline for the diagnosis and treatment of scabies in\n                        Japan","volume":"44","author":"Executive Committee of Guideline for the Diagnosis and Treatment of\n                            Scabies","year":"2017","journal-title":"J Dermatol"},{"issue":"1","key":"key2.0241212065459e+13_B9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1203475420960446","article-title":"Scabies: diagnostic and therapeutic update","volume":"25","author":"Richards","year":"2021","journal-title":"J Cutan Med Surg"},{"key":"key2.0241212065459e+13_B10","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-251842","article-title":"Successful treatment of refractory crusted\n                        scabies","volume":"15","author":"Nishizawa","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"8","key":"key2.0241212065459e+13_B11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMct0910329","article-title":"Permethrin and ivermectin for scabies","volume":"362","author":"Currie","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"key2.0241212065459e+13_B12","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/ddg.13130","article-title":"S1 guidelines on the diagnosis and treatment of scabies \u2013\n                        short version","volume":"14","author":"Sunderk\u00f6tter","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"key2.0241212065459e+13_B13","first-page":"196","article-title":"Recommendations for the treatment of scabies infestations in\n                        Israel","volume":"8","author":"Mumcuoglu","year":"2006","journal-title":"Isr Med Assoc J"},{"issue":"2","key":"key2.0241212065459e+13_B14","first-page":"170","article-title":"Efficacy and transdermal absorption of permethrin in scabies\n                        patients","volume":"69","author":"van der Rhee","year":"1989","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"key2.0241212065459e+13_B15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s001050050003","article-title":"Die skabiestherapie unter besonderer ber\u00fccksichtigung des\n                        fr\u00fchen kindesalters, der schwangerschaft und\n                        stillzeit","volume":"51","author":"F\u00f6lster-Holst","year":"2000","journal-title":"Hautarzt"},{"issue":"24","key":"key2.0241212065459e+13_B16","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass drug administration for scabies control in a population with\n                        endemic disease","volume":"373","author":"Romani","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"key2.0241212065459e+13_B17","first-page":"CD000320","article-title":"Interventions for treating scabies","volume":"2007","author":"Strong","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"key2.0241212065459e+13_B18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.det.2018.02.009","article-title":"Scabies itch","volume":"36","author":"Jannic","year":"2018","journal-title":"Dermatol Clin"},{"issue":"1","key":"key2.0241212065459e+13_B19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s13071-017-2320-4","article-title":"Host immune responses to the itch mite, Sarcoptes scabiei, in\n                        humans","volume":"10","author":"Bhat","year":"2017","journal-title":"Parasit Vectors"},{"issue":"9","key":"key2.0241212065459e+13_B20","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/jdv.17334","article-title":"Scabies itch: an update on neuroimmune interactions and novel\n                        targets","volume":"35","author":"Kim","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"key2.0241212065459e+13_B21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jaad.2019.05.109","article-title":"Ectoparasites: scabies","volume":"82","author":"Thomas","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"key2.0241212065459e+13_B22","first-page":"695","article-title":"Scabies: epidemiology, diagnosis, and treatment","volume":"118","author":"Sunderk\u00f6tter","year":"2021","journal-title":"Dtsch Arztebl Int"},{"issue":"9","key":"key2.0241212065459e+13_B23","doi-asserted-by":"crossref","first-page":"adv00112","DOI":"10.2340\/00015555-3468","article-title":"The management of scabies in the 21st century: past, advances and\n                        potentials","volume":"100","author":"Bernigaud","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"key2.0241212065459e+13_B24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/2229-5178.105486","article-title":"Treatment of nodular scabies with topical\n                        tacrolimus","volume":"4","author":"Mittal","year":"2013","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"key2.0241212065459e+13_B25","first-page":"43","article-title":"The prognosis of post-scabetic itch","volume":"61","author":"Kim","year":"2023","journal-title":"J Korean Dermatol Assoc"},{"key":"key2.0241212065459e+13_B26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fmed.2018.00333","article-title":"The antipruritic effect of phototherapy","volume":"5","author":"Legat","year":"2018","journal-title":"Front Med"},{"issue":"02","key":"key2.0241212065459e+13_B27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3855\/jidc.15222","article-title":"Scabies: update on treatment and efforts for prevention and\n                        control in highly endemic settings","volume":"16","author":"Widaty","year":"2022","journal-title":"J Infect Dev Ctries"},{"issue":"3","key":"key2.0241212065459e+13_B28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/tmi.13198","article-title":"Treatment, prevention and public health management of impetigo,\n                        scabies, crusted scabies and fungal skin infections in endemic populations:\n                        a systematic review","volume":"24","author":"May","year":"2019","journal-title":"Trop Med Int Health"},{"issue":"1","key":"key2.0241212065459e+13_B29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/diseases7010003","article-title":"Infected with scabies again? Focus in management in long-term\n                        care facilities","volume":"7","author":"Ong","year":"2018","journal-title":"Diseases"},{"key":"key2.0241212065459e+13_B30","volume-title":"Infection prevention and control\u2013standard operating procedure for\n                        scabies in a healthcare setting","author":"McCarthy-Khan","year":"2021"},{"key":"key2.0241212065459e+13_B31","volume-title":"Guide for prevention and management of scabies and head lice","author":"Korea Disease Control and Prevention Agency","year":"2018"},{"key":"key2.0241212065459e+13_B32","volume-title":"Guide for prevention and management of scabies in convalescent\n                        hospital","author":"Korea Disease Control and Prevention Agency","year":"2019"}],"container-title":["The Ewha Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.e-emj.org\/download\/download_pdf?doi=10.12771\/emj.2024.e72","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.e-emj.org\/download\/download_pdf?doi=10.12771\/emj.2024.e72","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T02:09:26Z","timestamp":1741226966000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-emj.org\/journal\/view.php?doi=10.12771\/emj.2024.e72"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,10,31]]}},"alternative-id":["10.12771\/emj.2024.e72"],"URL":"https:\/\/doi.org\/10.12771\/emj.2024.e72","relation":{},"ISSN":["2234-2591"],"issn-type":[{"value":"2234-2591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]},"assertion":[{"value":"2024-10-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e72"}}